TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 57 filers reported holding TRINITY BIOTECH PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,291,000 | -5.9% | 230,145 | +0.7% | 0.00% | -50.0% |
Q2 2017 | $1,372,000 | +0.8% | 228,609 | +0.1% | 0.00% | 0.0% |
Q1 2017 | $1,361,000 | -13.9% | 228,391 | +0.0% | 0.00% | 0.0% |
Q4 2016 | $1,580,000 | -53.2% | 228,373 | -10.6% | 0.00% | -60.0% |
Q3 2016 | $3,376,000 | +16.6% | 255,360 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $2,896,000 | +3.6% | 255,360 | +6.5% | 0.01% | 0.0% |
Q1 2016 | $2,795,000 | – | 239,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
RK Capital | 375,043 | $6,852,000 | 1.40% |
KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |